[Automatic translation follows] Official account of the Ministry of Health and Prevention The Ministry of Labor, Health and Solidarity prepares and implements Government policy in the areas of public health, prevention and access to care. health, solidarity, public administration, poverty, care, and solidarity

Smart technology for smarter mobility. As a technology company and partner to all automakers and new mobility players, Valeo innovates to make mobility cleaner, safer and smarter. Valeo is a technological and industrial leader in electrification, driving assistance systems, reinvention of the interior experience and lighting everywhere. These four areas, vital to the transformation of mobility, are the Group's growth drivers. Valeo in figures: 20 billion euros in sales in 2022; 109,900 employees at December 31, 2022; 29 countries, 183 plants, 21 research centers, 44 development centers, 18 distribution platforms. Valeo is listed on the Paris Stock Exchange. -- Valeo, …

Sectors: Automobile

[Automatic translation follows] Welcome to the Jungle offers solutions to make work exciting and sustainable. At Welcome to the Jungle, we work to make work exciting and sustainable. How ? By offering innovative solutions to companies so that they can develop their employer brand and strengthen their attractiveness. But also by creating an experience and inspiring content that gives the keys to workers and companies to redefine the rules of work. Our job board helps digital talents explore the professional world and find the most exciting opportunities. All thanks to the wealth of our content and our thousands of job …

Sectors: Human ressources

[Automatic translation follows] Official account of the Ministry of Labor, Full Employment and Integration The Ministry of Labor, Health and Solidarity prepares and implements Government policy in the areas of work, employment, vocational training, social dialogue and the prevention of workplace accidents and professional diseases. Employment, Vocational training, Labor law, Occupational health, Training, Social dialogue, and Union representation

[Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospital establishments. Founded in 1909 on a model designed by Marie Curie and still at the forefront, “from fundamental research to innovative care”, the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Cares The Institut Curie Hospital Complex is a reference center for breast cancers, eye tumors and pediatric cancers in particular. The research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians …

Sectors: Health

[Automatic translation follows] The media of digital transformation L’Usine Digitale (www.usine-digitale.fr) is THE media for the digital transformation of the economy. Every day, the editorial team unearths the technological innovations and new business models that will transform the economy of tomorrow. It also deciphers the best practices of companies (large groups, SMEs, start-ups, etc.), all sectors combined, and analyzes the underlying trends in high tech.

Innovation for Freedom OVHcloud is a global player and the leading European cloud provider operating over 450,000 servers within 37 data centers across 4 continents to reach 1,6 million customers in over 140 countries. Spearheading a trusted cloud and pioneering a sustainable cloud with the best price-performance ratio, the Group has been leveraging for over 20 years an integrated model that guarantees total control of its value chain: from the design of its servers to the construction and management of its data centers, including the orchestration of its fiber-optic network. This unique approach enables OVHcloud to independently cover all the …

Sectors: IT services

[Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Pharmaceutical Companies, brings together companies in the pharmaceutical industry sector in France. Created more than 130 years ago, Leem today has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in more than 150 professions, and has recruited 10,000 employees per year for 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its R&D centers, …

Sectors: Startup accelerator & VC

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies, from start-up to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region adapted to each stage of the life of companies. As a partner bank for entrepreneurs, Bpifrance supports them over the long term to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: …

Sectors: Biotechnology Startup accelerator & VC

Veolia is the benchmark company for ecological transformation. Veolia group aims to be the benchmark company for ecological transformation. With nearly 220,000 employees worldwide, the Group designs and provides game-changing solutions that are both useful and practical for water, waste and energy management. Through its three complementary business activities, Veolia helps to develop access to resources, preserve available resources, and replenish them. In 2021, the Veolia group supplied 79 million people with drinking water and 61 million people with wastewater service, produced nearly 48 million megawatt hours of energy and treated 48 million metric tons of waste. Veolia Environnement (listed …

Tags: CAC40 Sectors: Energy

20 ans au service des startups innovantes. #incubateur #deeptech Agoranov is an incubator for innovative startups. It has already incubated more than 450 startups, including 5 "unicorns" (valued at over one billion dollars), as well as many successful companies, such as Ÿnsect or DNA Script. Incubated startups have already managed to create more than 12,500 jobs and have raised over 2.5 billion euros from private funds. Agoranov est un incubateur de startups innovantes. Agoranov a déjà incubé plus de 450 startups, dont 5 "licornes" (startup valorisée à plus d'un milliard de dollars), ainsi que beaucoup de grands succès, comme Ÿnsect …

Sectors: Startup accelerator & VC

Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. We are driven by the excitement of building technologies, inventing products, and providing services that change lives. We embrace new ways of doing things, make decisions quickly, and are not afraid to fail. We have the scope and capabilities of a large company, and the spirit and heart of a small one. Together, Amazonians research and develop new technologies from Amazon Web Services to Alexa on behalf of our customers: shoppers, sellers, content creators, and developers around the …

Sectors: Consumer Electronics IT services

[Automatic translation follows] French data protection authority Created in 1978, the CNIL is an independent administrative authority which exercises its functions in accordance with the Data Protection Act of January 6, 1978, amended on August 6, 2004. legal, right of access, regulation, files, Data Protection Act, NICT, privacy, data, and dpo

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, …

Sectors: Pharmaceutical

[Automatic translation follows] L'Argus de l'Assurance, the reference press title in the insurance sector. Media from the Infopro Digital group. Argus de l’assurance is the leading source of information for insurance professionals. Thanks to its 12 specialized journalists (including a lawyer), the largest editorial team dedicated to this sector, Argus de l'assurance processes and analyzes all the news: developments in markets and distribution networks, company strategies , consumer trends, product innovations, regulations, movements... Since its creation in 1877, Argus insurance has evolved to help and support professionals. In addition to the weekly paper, Argus de l’assurance is also: - A …

Sectors: Insurance

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, and Primary Care

Sectors: Pharmaceutical

[Automatic translation follows] A major player in the social and solidarity economy, Mutualité Française, chaired by Eric Chenut, represents nearly 500 mutual societies. Born from the desire of women and men to protect themselves jointly from the vagaries of life, mutual societies are non-profit partnerships. They are chaired by elected mutualist activists. They act for the social protection of 32 million French people and promote the right of all to full health by intervening in complementarity and in partnership with Social Security and by contributing to the public health service. Mutual societies, groups and unions offer solutions in three areas …

Sectors: Health Insurance Mutual insurance

Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With close to 1,930 listed issuers and around €6.8 trillion in market capitalisation as of end March 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total …

Sectors: Finance

We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to continue to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases. For more information on the acquisition, see our press release at: http://bit.ly/3UbQcnl Hematology, Oncology, Inflammation, Immunology, Cancer, R&D, Innovation, Immunooncology, biopharma, Epigenetics, Protein Homeostasis, Translation Medicine, and Orphan diseases

Sectors: Pharmaceutical

Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. With approximately 7000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, …

Sectors: Biotechnology

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

Making the world a better home Saint-Gobain designs, manufactures and distributes materials and solutions for the construction, mobility and industrial markets. Developed through a continuous innovation process, our integrated solutions provide sustainability and performance in daily life, addressing the renovation of public and private buildings, light construction and the decarbonization of construction and industry. In this way, we contribute to reducing carbon emissions, leveraging resource efficiency and increasing circularity. Saint-Gobain believes in progress and seeks to be a game-changer that improves individual and collective health and wellness. We are convinced that the solutions that meet everyone’s essential needs and allow …

Tags: CAC40 Sectors: Building supplies

At Orange, you can. Orange is one of the world’s leading telecommunications operators with sales of 43.5 billion euros in 2022 and 136,000 employees worldwide at 31 December 2022, including 75,000 employees in France. The Group has a total customer base of 287 million customers worldwide at 31 December 2022, including 242 million mobile customers and 24 million fixed broadband customers. The Group is present in 26 countries. Orange is also a leading provider of global IT and telecommunication services to multinational companies under the brand Orange Business. In February 2023, the Group presented its strategic plan « Lead the …

Tags: CAC40 Sectors: Law Practice Telecoms

Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and …

Sectors: French Cluster Public business cluster

Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par …

Sectors: Health

We advance science so that we all have more time with the people we love. Are you ready to join us? Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is …

Sectors: Biotechnology Pharmaceutical

Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Pharmaceuticals, Therapeutics, …

Sectors: Pharmaceutical

We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them.

Sectors: Pharmaceutical

Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using …

Sectors: Biotechnology Pharmaceutical

What science can do We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business

Sectors: Pharmaceutical

#WeareBiotech Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world …

Sectors: Biotechnology

Rare inspiration. Changing lives. Our mission is to transform the lives of people living with rare diseases and devastating conditions through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in …

Sectors: Biotechnology Pharmaceutical

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care

Sectors: Pharmaceutical

Our people are our strength. And, together with over 56,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing

Sectors: Animal Health Pharmaceutical